Exact Mass: 456.0807

Exact Mass Matches: 456.0807

Found 20 metabolites which its exact mass value is equals to given mass value 456.0807, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lemildipine

{[4-(2,3-dichlorophenyl)-5-(methoxycarbonyl)-6-methyl-3-[(propan-2-yloxy)carbonyl]-1,4-dihydropyridin-2-yl]methoxy}carboximidic acid

C20H22Cl2N2O6 (456.0855)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

Xanthopappin C

Xanthopappin C

C27H20O3S2 (456.0854)


   

Maybridge1_001051

Maybridge1_001051

C19H16ClF3N4O4 (456.0812)


   

ZINC1030365

ZINC1030365

C19H16F4N4O3S (456.0879)


   

Cys Cys Cys Glu

(2S)-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C14H24N4O7S3 (456.0807)


   

Cys Cys Glu Cys

(4S)-4-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C14H24N4O7S3 (456.0807)


   

Cys Glu Cys Cys

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C14H24N4O7S3 (456.0807)


   

Glu Cys Cys Cys

(4S)-4-amino-4-{[(1R)-1-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C14H24N4O7S3 (456.0807)


   

(tert-Butoxycarbonylmethyl)triphenylphosphanium bromide

(tert-Butoxycarbonylmethyl)triphenylphosphanium bromide

C24H26BrO2P (456.0854)


   

Poly(oxy-1,2-ethanediyl), .alpha.-tridecyl-.omega.-hydroxy-, phosphate, potassium salt

Poly(oxy-1,2-ethanediyl), .alpha.-tridecyl-.omega.-hydroxy-, phosphate, potassium salt

C15H32K3O6P (456.0848)


   

Phosphonium,(4-ethoxy-4-oxobutyl)triphenyl-, bromide (1:1)

Phosphonium,(4-ethoxy-4-oxobutyl)triphenyl-, bromide (1:1)

C24H26BrO2P (456.0854)


   

(5-Carboxypentyl) triphenyl phosphonium bromide

(5-Carboxypentyl) triphenyl phosphonium bromide

C24H26BrO2P (456.0854)


   

2-(1,3-Dioxan-2-yl)ethyltriphenylphosphonium bromide

2-(1,3-Dioxan-2-yl)ethyltriphenylphosphonium bromide

C24H26BrO2P (456.0854)


   

2-AMINO-3,6-DICHLOROBENZOICACID

2-AMINO-3,6-DICHLOROBENZOICACID

C24H26BrO2P (456.0854)


   

Lemildipine

Lemildipine

C20H22Cl2N2O6 (456.0855)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

N-[4-[[2-(4-hydroxyphenyl)-1,3-dioxo-5-isoindolyl]oxy]phenyl]-2-thiophenecarboxamide

N-[4-[[2-(4-hydroxyphenyl)-1,3-dioxo-5-isoindolyl]oxy]phenyl]-2-thiophenecarboxamide

C25H16N2O5S (456.078)


   

Tinlorafenib

Tinlorafenib

C19H19ClF2N4O3S (456.0834)


Tinlorafenib (PF-07284890) (compound 10) is an orally active BRAF kinase inhibitor, with IC50s of 4.25 and 2.7 nM for BRAFV600E/V600K respectively. Tinlorafenib demonstrates CNS penetration and can be used in the research of BRAF-associated malignant and benign tumors of the CNS as well as extracranial malignancies[1].

   

(2s)-1,2-bis({5-[(5e)-hept-5-en-1,3-diyn-1-yl]thiophen-2-yl})-2-hydroxypentane-1,4-dione

(2s)-1,2-bis({5-[(5e)-hept-5-en-1,3-diyn-1-yl]thiophen-2-yl})-2-hydroxypentane-1,4-dione

C27H20O3S2 (456.0854)


   

1,2-bis[5-(hept-5-en-1,3-diyn-1-yl)thiophen-2-yl]-2-hydroxypentane-1,4-dione

1,2-bis[5-(hept-5-en-1,3-diyn-1-yl)thiophen-2-yl]-2-hydroxypentane-1,4-dione

C27H20O3S2 (456.0854)


   

1,2-bis({5-[(5e)-hept-5-en-1,3-diyn-1-yl]thiophen-2-yl})-2-hydroxypentane-1,4-dione

1,2-bis({5-[(5e)-hept-5-en-1,3-diyn-1-yl]thiophen-2-yl})-2-hydroxypentane-1,4-dione

C27H20O3S2 (456.0854)